ASSESSMENT OF SERUM ALARIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.

Kilinc, F; Demircan, F; Gozel, N; Onalan, E; Karatas, A; Pekkolay, Z; Özdemir, F A

Kilinc, F; Demircan, F; Gozel, N; Onalan, E; Karatas, A; Pekkolay, Z; Özdemir, F A.

Afiliación

Kilinc F; Firat University, School of Medicine, Dept. of Endocrinology, Turkey.
Demircan F; Private Etik Life Medical Center Dept. of Internal Diseases, Istanbul, Turkey.
Gozel N; Dept. of Internal Medicine, Turkey.
Onalan E; Dept. of Medical Biology, Turkey.
Karatas A; Dept. of Rheumatology, Elazig, Turkey.
Pekkolay Z; Dicle University, School of Medicine, Dept. of Endocrinology, Diyarbakir, Turkey.
Özdemir FA; Bingol University, School of Sciences, Dept. of Molecular Biology and Genetics, Bingol, Turkey.

Acta Endocrinol (Buchar) ; 16(2): 165-169, 2020.

Article en En | MEDLINE | ID: mdl-33029232

Palabras clave

Type 2 diabetes mellitus; alarin level; diabetic complications

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Acta Endocrinol (Buchar) Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Rumanía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google